ATE109793T1 - Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. - Google Patents

Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.

Info

Publication number
ATE109793T1
ATE109793T1 AT88304551T AT88304551T ATE109793T1 AT E109793 T1 ATE109793 T1 AT E109793T1 AT 88304551 T AT88304551 T AT 88304551T AT 88304551 T AT88304551 T AT 88304551T AT E109793 T1 ATE109793 T1 AT E109793T1
Authority
AT
Austria
Prior art keywords
linear
alpha
analogues
cyclic analogues
extraordinary effects
Prior art date
Application number
AT88304551T
Other languages
English (en)
Inventor
Victor J Hruby
Fahad A Al-Obeidi
Mac E Hadley
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Application granted granted Critical
Publication of ATE109793T1 publication Critical patent/ATE109793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88304551T 1987-05-22 1988-05-19 Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. ATE109793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
CA000578920A CA1340107C (en) 1987-05-22 1988-09-30 Linear and cyclic analoques of alpha-msh fragments with extraordinary potency

Publications (1)

Publication Number Publication Date
ATE109793T1 true ATE109793T1 (de) 1994-08-15

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88304551T ATE109793T1 (de) 1987-05-22 1988-05-19 Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.

Country Status (11)

Country Link
EP (1) EP0292291B1 (de)
JP (1) JPH0826077B2 (de)
CN (1) CN1031242C (de)
AT (1) ATE109793T1 (de)
CA (1) CA1340107C (de)
DE (1) DE3851002T2 (de)
DK (1) DK172760B1 (de)
FI (1) FI882380A7 (de)
IE (1) IE64903B1 (de)
PH (1) PH25819A (de)
PT (1) PT87560B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
EP0389950A1 (de) * 1989-03-23 1990-10-03 Lion Corporation Inhibitor des melanocytenstimulierenden Hormons und dieses enthaltendes, äusserlich anwendbares Präparat
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
WO1994022460A1 (en) * 1993-04-05 1994-10-13 University Patents, Inc. Diagnosis and treatment of erectile dysfunction
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5420109A (en) 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
HK1044954B (en) 1999-03-29 2008-11-21 The Procter & Gamble Company Melanocortin receptor ligands
TW200718944A (en) * 1999-06-29 2007-05-16 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
JP2007532471A (ja) 2003-09-30 2007-11-15 ノボ ノルディスク アクティーゼルスカブ 新規メラノコルチンレセプターアゴニスト
NZ554427A (en) * 2004-10-08 2010-09-30 Clinuvel Pharmaceuticals Ltd Compositions and methods for inducing melanogenesis in a subject utilising afamelanotide
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α-黑素细胞刺激素类似物及其用途
EP1915168A4 (de) 2005-07-08 2010-03-31 Ipsen Pharma Liganden von melanocortin-rezeptoren
US20110130705A1 (en) 2008-03-27 2011-06-02 Clinuvel Pharmaceuticals Limited Therapy for vitiligo
EP2300036B1 (de) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin-rezeptor-spezifische peptide zur behandlung von sexueller dysfunktion
CA2733790A1 (en) 2008-08-20 2010-02-25 Ensemble Discovery Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
EP2504351A4 (de) 2009-11-23 2013-10-30 Palatin Technologies Inc Melanocortin-1-rezeptor-spezifische lineare peptide
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
JP6622690B2 (ja) 2013-03-15 2019-12-18 リズム・ファーマシューティカルズ・インコーポレイテッド ペプチド組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
FI882380A7 (fi) 1988-11-23
CN1031242C (zh) 1996-03-13
EP0292291B1 (de) 1994-08-10
DK277788A (da) 1988-11-23
IE881537L (en) 1988-11-22
DE3851002T2 (de) 1995-02-02
JPH0826077B2 (ja) 1996-03-13
AU1650688A (en) 1988-11-24
JPS6470499A (en) 1989-03-15
PT87560A (pt) 1989-05-31
DE3851002D1 (de) 1994-09-15
FI882380A0 (fi) 1988-05-20
PT87560B (pt) 1992-09-30
PH25819A (en) 1991-11-05
DK277788D0 (da) 1988-05-20
IE64903B1 (en) 1995-09-20
EP0292291A3 (en) 1990-05-02
CN1032795A (zh) 1989-05-10
EP0292291A2 (de) 1988-11-23
CA1340107C (en) 1998-10-27
AU618733B2 (en) 1992-01-09
DK172760B1 (da) 1999-06-28

Similar Documents

Publication Publication Date Title
DE3851002D1 (de) Lineare und zyklische Analoge von alpha-MSH-Fragmenten mit ausserordentlicher Wirkung.
ATE358176T1 (de) Menschliche dnase
DK53497A (da) Osteoinduktive præparater
DE69201564D1 (de) Verwendung von metalloxidmanopigmenten zum schutz von haarkeratin vor äusseren einflüssen, insbesondere sonnenlicht, verfahren zum schutz des haares und gelzusammensetzung unter verwendung dieser nanopigmente.
KR860004920A (ko) 뉴클레오시드 및 이의 제조방법
FI844510A0 (fi) Ensym-resistenta immunsystemet modulerande peptider.
ATE119915T1 (de) Dns-sequenzen, rekombinante dns-moleküle und verfahren zur herstellung von ''mullerian inhibiting substance''-ähnlichen polypeptiden.
ATE79536T1 (de) Tamoxifen zur topischen verwendung.
EP0610286A4 (en) Recombinant immunotoxins.
ATE86488T1 (de) Verwendung von minoxidil zur wundheilung.
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
NO890046L (no) Disubstituerte pyridiner.
DE69012870D1 (de) Gateelektrodenimpulsgenerator zur statischen Var-Kompensation.
ATE76579T1 (de) Interferon-zusammensetzungen.
IT8723062A0 (it) Procedimento e dispositivo per registrare punti morti di filatura o torcitura.
FR2630430B1 (fr) Nouvelles compositions vitreuses luminescentes, leur preparation et leur application
IT1208760B (it) Trattamento delle malattie infiammatorie articolari
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
DE3879709D1 (de) Platin-arzneimittel.
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
DE3884407D1 (de) Trifluormethyl-1-tetralinabkömmlinge, deren herstellung und verwendung bei der herstellung von verbindungen mit therapeutischer wirkung.
FI880801A7 (fi) Puun käsittelyyn tarkoitetut koostumukset ja menetelmät puun käsittelemiseksi.
ES285527U (es) Estante perfeccionado